Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 74.98

-1.9%

Nov 20 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (1380)	8/24/2005 1:27:26 PM
From: Jibacoa	Read Replies (1) of 3722

COR Is also going over its July Hs as it continues with yesterday's up-move. The next hurdle is the resistance from its June Hs at the 2.60 level. The stock is up almost 7% and it hasn't closed yesterday's upgap. bigcharts.marketwatch.com It announced that its chairman and CEO,Roger G. Stoll, Ph.D., will speak at the Conference in NY by Roth Capital Partners on Thursday, September 8. Cortex is developing ampakine compounds that amplify the effects of glutamate in the brain. In January it received an FDA approval to start a PII of CX717 in neuropsychiatric conditions. It reportedly has around $0.75 in cash/shr and no significant LTD. Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next